MCF Advisors’s Avita Medical RCEL Stock Holding History

MCF Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-36,812	Closed	-$538K	–	978
2023 Q3	$538K	Hold	36,812	–	–	0.05%	115
2023 Q2	$626K	Hold	36,812	–	–	0.06%	103
2023 Q1	$514K	Hold	36,812	–	–	0.05%	122
2022 Q4	$243K	Hold	36,812	–	–	0.02%	190
2022 Q3	$194K	Hold	36,812	–	–	0.02%	197
2022 Q2	$175K	Hold	36,812	–	–	0.02%	201
2022 Q1	$312K	Buy	+36,812	New	+$339K	0.03%	154
2021 Q4	–	Sell	-36,812	Closed	-$652K	–	527
2021 Q3	$652K	Hold	36,812	–	–	0.07%	86
2021 Q2	$755K	Hold	36,812	–	–	0.08%	68
2021 Q1	$730K	Hold	36,812	–	–	0.08%	64
2020 Q4	$684K	Hold	36,812	–	–	0.08%	62
2020 Q3	$926K	Buy	36,812 +20,745	+129%	+$517K	0.12%	47
2020 Q2	$491K	Buy	16,067 +12,067	+302%	+$369K	0.07%	74
2020 Q1	$124K	Hold	4,000	–	–	0.02%	166
2019 Q4	$182K	Buy	+4,000	New	+$166K	0.03%	156

Other funds holding RCEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MCF Advisors's RCEL Position: Q4 2023 in Review

MCF Advisors sold out of Avita Medical (RCEL) in Q4 2023, closing a stake of 36,812 shares — an estimated $538K sold.

MCF Advisors first reported a position in RCEL in Q4 2019 and held it in 15 quarters. The position peaked at $926K in Q3 2020. 84 funds tracked by Wall St. Rank hold RCEL as of Q4 2023.

MCF Advisors reported no remaining Avita Medical position as of Q4 2023 after selling out during the quarter.
MCF Advisors sold 36,812 Avita Medical shares in Q4 2023, an estimated $538K.
MCF Advisors first reported a position in Avita Medical in Q4 2019 and held it in 15 quarters.
MCF Advisors's Avita Medical position peaked at $926K in Q3 2020.
84 funds tracked by Wall St. Rank held Avita Medical as of Q4 2023.

Based on MCF Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.